We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Evolus Inc | NASDAQ:EOLS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.08 | 0.61% | 13.30 | 11.65 | 13.90 | 13.54 | 13.20 | 13.40 | 1,126,051 | 23:52:51 |
Event: | Cantor Global Healthcare Conference | |
Date: | Monday, October 1, 2018 | |
Time: | 8:55 AM ET | |
Location: | Intercontinental New York Barclay Hotel, New York, NY |
A live audio webcast of the event can be accessed on the Events & Presentations page of the Investors section of Evolus’s website at http://www.evolus.com, or by following the link below in your web browser. An archived replay of the webcast will be available on Evolus’s website for 30 days after the live event concludes.
Webcast Link: http://wsw.com/webcast/cantor7/eols/
About Evolus, Inc.
Evolus is a company dedicated to aesthetic medicine focused on providing physicians and their patients with expanded choices in aesthetic treatments and procedures. Evolus’ lead candidate DWP-450, also known by the chemical name prabotulinumtoxinA, is a 900 kDa purified botulinum toxin type A complex that was approved by Health Canada for the temporary improvement in the appearance of moderate to severe glabellar lines in adult patients under 65 years of age and is being evaluated for marketing approval in the United States and other areas.
Evolus Contacts:
Investor Contacts:Ashwin Agarwal, EvolusTel: +1-949-284-4559Email: IR@Evolus.com
Brian Johnston, The Ruth Group Tel: +1 646-536-7028Email: IR@Evolus.com
Media Contact:Kirsten Thomas, The Ruth GroupTel: +1-508-280-6592Email: kthomas@theruthgroup.com
1 Year Evolus Chart |
1 Month Evolus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions